Literature DB >> 476643

Inhibition of human melanoma colony formation by retinoids.

F L Meyskens, S E Salmon.   

Abstract

We studied the effects of retinoids on the in vitro survival of melanoma colony-forming cells in biopsies obtained from ten patients with metastatic melanoma. The results indicate that specific retinoids reduce the ability of fresh human melanoma cells to form colonies in soft agar. The retinoids studied had differential effects on the survival of clonogenic melanoma cells, and these effects vary from patient to patient. The data provide support for the clinical trial of selected retinoids in micrometastatic and advanced melanoma.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 476643

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  16 in total

1.  Comparison of the colony forming ability and invasive potential of six primate cell lines treated with retinoic acid.

Authors:  T Saiga; D E Wierenga; I Levenbook; J C Petricciani
Journal:  Invest New Drugs       Date:  1986       Impact factor: 3.850

2.  A phase II study of alpha-difluoromethylornithine (DFMO) for the treatment of metastatic melanoma.

Authors:  F L Meyskens; E M Kingsley; T Glattke; L Loescher; A Booth
Journal:  Invest New Drugs       Date:  1986       Impact factor: 3.850

Review 3.  The human tumor cloning assay in cancer drug development. A review.

Authors:  P Agre; T E Williams
Journal:  Invest New Drugs       Date:  1983       Impact factor: 3.850

4.  Phase II trial of beta-all-trans-retinoic acid for cervical intraepithelial neoplasia delivered via a collagen sponge and cervical cap.

Authors:  V Graham; E S Surwit; S Weiner; F L Meyskens
Journal:  West J Med       Date:  1986-08

5.  Antitumor activity of didemnin B in the human tumor stem cell assay.

Authors:  T L Jiang; R H Liu; S E Salmon
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

6.  Phase II study of alpha-interferon and 13-cis-retinoic acid in metastatic melanoma.

Authors:  K Dhingra; N Papadopoulos; S Lippman; R Lotan; S S Legha
Journal:  Invest New Drugs       Date:  1993-02       Impact factor: 3.850

Review 7.  Etretinate. A review of its pharmacological properties and therapeutic efficacy in psoriasis and other skin disorders.

Authors:  A Ward; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1983-07       Impact factor: 9.546

8.  Quantitative association between the in vitro human tumor stem cell assay and clinical response to cancer chemotherapy.

Authors:  T E Moon; S E Salmon; C S White; H S Chen; F L Meyskens; B G Durie; D S Alberts
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

Review 9.  Role of laboratory chemosensitivity testing in the selection of cancer chemotherapy for individual patients.

Authors:  P J Selby; D Raghavan
Journal:  J Clin Pathol       Date:  1981-05       Impact factor: 3.411

10.  Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid.

Authors:  T R Breitman; S E Selonick; S J Collins
Journal:  Proc Natl Acad Sci U S A       Date:  1980-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.